← SynDRA
GW501516
SynDRA canonical compound SYN0002026 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PPARD |
|---|
| Mechanism of action | PPAR receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Insulin sensitizer
- PPAR receptor agonist
- PPARD AGONIST
- Peroxisome proliferator-activated receptor delta agonist
- PPARD FULL AGONIST
- PPARD MODULATOR
Cross-references
Synonyms
- Cardarine
- Gw-501516
- GSK-516
- GW-1516
- GW 501516
- Endurobol
- UNII-7I2HA1NU22
- GW1516
- 2-(2-Methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methyl)thio)phenoxy)acetic acid
- GW-516
- CHEMBL38943
- 2-(2-methyl-4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methylthio)phenoxy)acetic acid
- 2-(4-((2-(4-(Trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid
- 7I2HA1NU22
- GW-501516
- GSK 516
- GW 1516
- CHEBI:73726
- RefChem:574663
- DTXCID1021037
- MFCD09033000
- GW501,516
- GW-501,516
- C21H18F3NO3S2
- GW501516 (Endurobol)
- SCHEMBL68714
- MLS006010753
- GW 501516 (Standard)
- ENDUROBOL;GW501516
- GTPL2687
- orb1301031
- orb3025490
- SCHEMBL29356729
- BDBM28661
- EX-A723
- GLXC-03110
- HMS3674C03
- HMS3744O09
Look up GW501516 in the interactive SynDRA portal →